PC Group, Inc. (PCGR)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
PC Group, Inc. (PCGR) with AI Score 48/100 (Weak). PC Group, Inc. focuses on personal care products for private label retail, medical, and therapeutic markets. Market cap: 0, Sector: Consumer defensive.
Last analyzed: Mar 17, 2026PC Group, Inc. (PCGR) Consumer Business Overview
PC Group, Inc. (PCGR) provides personal care and medical products, including soaps, cleansers, and gel-based orthopedic solutions, primarily in the United States, Canada, and Europe. Targeting private label retail, medical, and therapeutic markets, PCGR operates in the competitive household and personal products sector.
Investment Thesis
PC Group, Inc. operates in the consumer defensive sector, specifically within household and personal products. With a market capitalization of $0.00B and a negative P/E ratio, the company's financial performance requires careful consideration. A gross margin of 27.4% and a negative profit margin of -3.0% indicate potential challenges in profitability. The company's beta of 0.47 suggests lower volatility compared to the market. Growth catalysts include expanding its product offerings in the gel-based orthopedic segment and increasing its distribution network. However, risks include intense competition and the need to improve profitability. The company's shift in focus to personal care products in 2009 and its established presence in the US, Canada, and Europe provide a foundation for potential future growth.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $0.00B indicates a micro-cap company with limited financial resources.
- Negative P/E Ratio suggests the company is currently not profitable.
- Gross Margin of 27.4% reflects the company's ability to generate revenue after accounting for the cost of goods sold.
- Profit Margin of -3.0% indicates the company is operating at a loss.
- Beta of 0.47 suggests the stock is less volatile than the overall market.
Competitors & Peers
Strengths
- Established presence in the United States, Canada, and Europe.
- Expertise in gel-based orthopedic products.
- Relationships with private label retailers.
- Diverse product portfolio in personal care and medical sectors.
Weaknesses
- Negative profit margin.
- Limited market capitalization.
- Dependence on private label retail partnerships.
- Intense competition in the household and personal products industry.
Catalysts
- Ongoing: Expansion of gel-based orthopedic product line to address growing market demand.
- Ongoing: Strengthening relationships with private label retailers to increase product distribution.
- Upcoming: Potential partnerships with new medical distributors to expand market reach.
- Upcoming: Development of new over-the-counter drug products to diversify product portfolio.
Risks
- Ongoing: Intense competition in the household and personal products industry.
- Potential: Economic downturns affecting consumer spending on personal care products.
- Potential: Regulatory changes in the personal care and medical products industries.
- Ongoing: Negative profit margin impacting financial stability.
- Potential: Limited liquidity due to OTC trading.
Growth Opportunities
- Expansion in Gel-Based Orthopedic Products: PC Group can capitalize on the growing demand for gel-based orthopedic products, including digitcare, diabetes management, and prosthetic solutions. The market for orthopedic products is projected to reach $60 billion by 2028, driven by an aging population and increasing prevalence of orthopedic conditions. PC Group's existing product line and distribution network provide a competitive advantage in capturing a larger share of this market. Timeline: 2-3 years.
- Increased Focus on Private Label Retail: PC Group can expand its partnerships with private label retailers to offer customized personal care products. The private label market is experiencing growth as consumers seek value and retailers aim to differentiate their offerings. PC Group's ability to provide tailored solutions and its established relationships with retailers position it well to capitalize on this trend. Market size: $200 billion. Timeline: Ongoing.
- Geographic Expansion in Europe: PC Group can further expand its presence in the European market by establishing new distribution channels and partnerships. The European personal care market is substantial, with a growing demand for specialized and medical-grade products. PC Group's existing operations in Europe provide a foundation for further growth. Market size: $150 billion. Timeline: 3-5 years.
- Development of New Over-the-Counter (OTC) Drug Products: PC Group can invest in the development of new OTC drug products, such as acne treatments and therapeutic solutions. The OTC market offers opportunities for growth, driven by increasing self-care trends and consumer demand for accessible healthcare solutions. PC Group's expertise in personal care and medical products can be leveraged to create innovative OTC offerings. Market size: $40 billion. Timeline: 2-4 years.
- Enhancement of E-Commerce Capabilities: PC Group can enhance its e-commerce capabilities to reach a broader customer base and improve online sales. The e-commerce channel is experiencing significant growth in the personal care and medical products sectors. By investing in a user-friendly online platform and digital marketing strategies, PC Group can increase its brand visibility and drive online sales. Market size: $250 billion. Timeline: Ongoing.
Opportunities
- Expansion in the gel-based orthopedic market.
- Increased focus on e-commerce channels.
- Development of new over-the-counter drug products.
- Geographic expansion in Europe.
Threats
- Intense competition from larger, more established companies.
- Changing consumer preferences and trends.
- Economic downturns affecting consumer spending.
- Regulatory changes in the personal care and medical products industries.
Competitive Advantages
- Established relationships with private label retailers.
- Specialized expertise in gel-based orthopedic products.
- Distribution network in the United States, Canada, and Europe.
- Focus on medical and therapeutic markets.
About PCGR
Founded in 1971 and headquartered in New York City, PC Group, Inc., formerly known as Langer, Inc., shifted its business focus to personal care products in July 2009. The company develops, manufactures, and markets a range of personal care and medical products through its subsidiaries. Its product portfolio includes soaps, cleansers, toners, moisturizers, exfoliants, and facial masks, along with over-the-counter drug products like acne soaps. PC Group also offers gel-based products, including gloves and socks for cosmetic and scar management, as well as gel-based orthopedic and prosthetic products for various applications. The company distributes its personal care products through account representatives to health and beauty companies, specialty retailers, cosmetics companies, direct marketing companies, amenities companies, health clubs and spas, and catalog companies. Medical products are sold through national and regional account managers, field sales representatives, inside sales representatives, and medical distributors. PC Group's strategic focus on private label retail and medical markets allows it to cater to specific customer needs with customized product solutions. The company operates primarily in the United States, Canada, and Europe, serving a diverse range of customers in the health and beauty and medical sectors.
What They Do
- Develops and manufactures personal care products.
- Offers private label retail solutions.
- Provides medical and therapeutic products.
- Produces soaps, cleansers, and moisturizers.
- Creates gel-based orthopedic products.
- Markets over-the-counter drug products.
- Sells products in the United States, Canada, and Europe.
Business Model
- Manufacturing and selling personal care products.
- Providing private label solutions for retailers.
- Distributing medical and therapeutic products through various channels.
- Generating revenue through product sales to health and beauty companies, retailers, and medical distributors.
Industry Context
PC Group, Inc. operates in the competitive household and personal products industry, which is characterized by established players and evolving consumer preferences. The industry includes companies that manufacture and distribute a wide range of personal care, cosmetic, and household products. Trends in the industry include a growing demand for natural and organic products, increased focus on sustainability, and the rise of e-commerce. PC Group competes with larger, more established companies, including BCCI (Big China Corp Inc), CRMBQ (Crumbs Bake Shop Inc), GEGI (Genesis Group Inc), MDAV (MedAvail Holdings Inc), and MFLTY (Moffett Lee & Co Inc). The company's focus on private label retail and medical markets provides a niche within the broader industry.
Key Customers
- Health and beauty companies.
- Specialty retailers.
- Cosmetics companies.
- Medical distributors.
- Direct marketing companies.
Financials
Chart & Info
PC Group, Inc. (PCGR) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Highs On Wednesday
· Sep 25, 2019
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PCGR.
Price Targets
Wall Street price target analysis for PCGR.
MoonshotScore
What does this score mean?
The MoonshotScore rates PCGR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Peter A. Asch
CEO
Peter A. Asch serves as the CEO of PC Group, Inc., overseeing the strategic direction and operational management of the company. His background includes extensive experience in the consumer products and healthcare industries. Prior to joining PC Group, Asch held leadership positions at various companies, focusing on product development, marketing, and sales. He brings a wealth of knowledge in managing and growing businesses in competitive markets. Asch's expertise is instrumental in guiding PC Group's growth and expansion strategies.
Track Record: Under Peter A. Asch's leadership, PC Group, Inc. has focused on expanding its product offerings and strengthening its relationships with private label retailers. Key milestones include the development of new gel-based orthopedic products and the expansion of the company's distribution network. Asch has also emphasized innovation and efficiency in operations to improve profitability. His strategic decisions have been crucial in navigating the challenges of the competitive personal care and medical products industries.
PCGR OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that PC Group, Inc. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not provide regular financial reporting, increasing the risk for investors. Trading on the OTC Other tier does not imply illegitimacy, but it does suggest a higher level of scrutiny is needed before investing compared to companies listed on major exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry.
- Lower trading volume can lead to price volatility.
- Wider bid-ask spreads can increase transaction costs.
- Potential for delisting or trading suspensions.
- Higher risk of fraud or manipulation compared to listed stocks.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive position.
- Evaluate the management team and their track record.
- Monitor trading volume and price activity.
- Understand the risks associated with OTC trading.
- Consult with a financial advisor before investing.
- Established history since 1971.
- Focus on personal care and medical products.
- Distribution network in the United States, Canada, and Europe.
- Shift to personal care products in 2009.
Common Questions About PCGR
What does PC Group, Inc. do?
PC Group, Inc. develops, manufactures, and markets personal care and medical products, primarily for the private label retail, medical, and therapeutic markets. Its product range includes soaps, cleansers, moisturizers, and gel-based orthopedic solutions. The company distributes its products through various channels, including account representatives, national and regional account managers, and medical distributors, serving customers in the United States, Canada, and Europe. PC Group's focus on private label solutions and specialized medical products differentiates it within the competitive consumer defensive sector.
What do analysts say about PCGR stock?
AI analysis is currently pending for PCGR. Given the company's negative P/E ratio and small market capitalization, a comprehensive analysis of its financial performance and growth potential is crucial. Investors should closely monitor the company's ability to improve profitability and expand its market share in the competitive household and personal products industry. The OTC listing and limited financial disclosure also warrant careful consideration of the associated risks.
What are the main risks for PCGR?
PCGR faces several risks, including intense competition in the household and personal products industry, which could limit its ability to gain market share. The company's negative profit margin poses a significant financial risk, requiring improvements in operational efficiency and cost management. As an OTC-listed stock, PCGR is subject to lower trading volumes and wider bid-ask spreads, increasing liquidity risk. Additionally, regulatory changes in the personal care and medical products industries could impact the company's operations and profitability.
How does PC Group, Inc. compete in the personal care market?
PC Group, Inc. competes by focusing on private label retail and specialized medical products. This strategy allows the company to cater to specific customer needs and differentiate itself from larger, more diversified competitors. By offering customized solutions and building strong relationships with retailers and medical distributors, PC Group aims to secure a niche in the competitive personal care market. The company's expertise in gel-based orthopedic products also provides a competitive advantage in the medical sector.
What is PCGR's strategy for improving profitability?
PCGR's strategy for improving profitability likely involves several key initiatives. These may include streamlining operations to reduce costs, focusing on higher-margin products such as gel-based orthopedic solutions, and expanding its distribution network to increase sales volume. The company may also explore strategic partnerships and acquisitions to leverage synergies and gain access to new markets. Effective implementation of these strategies will be crucial for PCGR to achieve sustainable profitability and improve its financial performance.
What are the key factors to evaluate for PCGR?
PC Group, Inc. (PCGR) currently holds an AI score of 48/100, indicating low score. Key strength: Established presence in the United States, Canada, and Europe.. Primary risk to monitor: Ongoing: Intense competition in the household and personal products industry.. This is not financial advice.
How frequently does PCGR data refresh on this page?
PCGR prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven PCGR's recent stock price performance?
Recent price movement in PC Group, Inc. (PCGR) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established presence in the United States, Canada, and Europe.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited, particularly given the OTC listing and unknown disclosure status.
- AI analysis is pending, so some conclusions are based on limited available information.